Skip to main content
. 2015 Oct 14;12(6):7869–7876. doi: 10.3892/mmr.2015.4443

Figure 4.

Figure 4

Effects of integrin β1 (ITGB1) inhibition and bevacizumab treatment on ovarian cancer cell adhesion. Data are presented as the mean ± standard deviation of duplicates from a representative experiment performed in triplicate. *P<0.01, vs. the control (Con) and lentiviral vector (LV)-negative control (NC) groups. **P<0.01, vs. the LV-ITGB1 and bevacizumab-treated (Beva) groups.